Arisglobal Acquires Boehringer Ingelheim'S Signal Analytics Engine, Bringing Enhanced And Unmatched Pharmacovigilance Capabilities To Life Sciences Industry
Arisglobal Acquires Boehringer Ingelheim'S Signal Analytics Engine, Bringing Enhanced And Unmatched Pharmacovigilance Capabilities To Life Sciences Industry
05/11/22, 1:10 PM
Location
walthamIndustry
software
science and engineering
ArisGlobal, the global market leader in drug safety solutions worldwide, and Boehringer Ingelheim, a leading research-driven biopharmaceutical company, today announced the acquisition of Boehringer Ingelheim's digital innovation, BRASS, by ArisGlobal. This data insights engine will be integrated into ArisGlobal's technology platform, LifeSphere®, under the name of LifeSphere Clarity, and will play a key role in driving industry-wide advancement of pharmacovigilance and patient safety.
Company Info
Location
Waltham, Massachusetts, United States
Company info
ArisGlobal is transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans almost 40 years, LifeSphere® boosts efficiency, ensures compliance, and reduces cost through multi-tenant Software-as-a-Service (SaaS) architecture.